Publications by authors named "Brigitte Tonnoir"

Claim this Profile
E
Efficacy and tolerability of vortioxetine versus agomelatine, categorized by previous treatment, in patients with major depressive disorder switched after an inadequate response.
George I Papakostas, Rebecca Z Nielsen, Marianne Dragheim, Brigitte Tonnoir

J Psychiatr Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder.
Roger S McIntyre, Ioana Florea, Brigitte Tonnoir, Henrik Loft, Raymond W Lam

J Clin Psychiatry· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder.
Siegfried Kasper, Bjarke Ebert, Klaus Larsen, Brigitte Tonnoir

Int J Neuropsychopharmacol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
Jean-Pierre Olié, Brigitte Tonnoir, François Ménard, André Galinowski

Depress Anxiety· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escitalopram prevents relapse of obsessive-compulsive disorder.
Naomi A Fineberg, Brigitte Tonnoir, Ole Lemming, Dan J Stein

Eur Neuropsychopharmacol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder.
Laurent Schmitt, Brigitte Tonnoir, Christophe Arbus

Neuropsychobiology· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study.
Dan J Stein, Elisabeth Wreford Andersen, Brigitte Tonnoir, Naomi Fineberg

Curr Med Res Opin· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis